Fidelity Investments
BTCY

Fidelity Investments’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Fidelity Investments’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17
Closed -$20 – 5790
2023
Q4 		$20 Hold
17
– – ﹤0.01% 5220
2023
Q3 		$36 Hold
17
– – ﹤0.01% 4989
2023
Q2 		$64 Buy
+17
New +$63 ﹤0.01% 4998

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Fidelity Investments's BTCY Position: Q1 2024 in Review

Fidelity Investments sold out of Biotricity, Inc. Common Stock (BTCY) in Q1 2024, closing a stake of 17 shares — an estimated $20 sold.

Fidelity Investments first reported a position in BTCY in Q2 2023 and held it in 3 quarters. The position peaked at $64 in Q2 2023. 18 funds tracked by Wall St. Rank hold BTCY as of Q1 2024.

  • Fidelity Investments reported no remaining Biotricity, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fidelity Investments sold 17 Biotricity, Inc. Common Stock shares in Q1 2024, an estimated $20.
  • Fidelity Investments first reported a position in Biotricity, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Fidelity Investments's Biotricity, Inc. Common Stock position peaked at $64 in Q2 2023.
  • 18 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.